Sort
30,917 grants matching “tumor microenvironment”
Non-perturbative imaging of intracellular drug exposure and drug response of kinase inhibitors
$385,003Dan Fu · University Of Washington · R35 · FY2021 · GM
Non-perturbative imaging of intracellular drug exposure and drug response of kinase inhibitors
$385,003Dan Fu · University Of Washington · R35 · FY2023 · GM
Non-perturbative imaging of intracellular drug exposure and drug response of kinase inhibitors
$385,003Dan Fu · University Of Washington · R35 · FY2020 · GM
Non-perturbative imaging of intracellular drug exposure and drug response of kinase inhibitors
$385,003Dan Fu · University Of Washington · R35 · FY2019 · GM
HSC transduction in situ by cellular delivery of integrating viral vectors
$385,000Peter Kurre · Oregon Health & Science University · R01 · FY2010 · HL
HSC transduction in situ by cellular delivery of integrating viral vectors
$385,000Peter Kurre · Oregon Health & Science University · R01 · FY2009 · HL
Core B: Animal Model and Immunotyping Core
$384,934Thomas Alan Hamilton · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · CA
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
$384,921Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Deciphering Mechanisms of Tumor-Stromal Interactions in Prostate Cancer
$384,901Boyang Wu · Washington State University · R01 · FY2025 · CA
Identifying novel therapies targeting Merkel cell carcinoma and tumor microenvironment
$384,870Ling Gao · Southern California Inst For Res/Educ · R01 · FY2022 · CA
Identifying novel therapies targeting Merkel cell carcinoma and tumor microenvironment
$384,870Ling Gao · Southern California Inst For Res/Educ · R01 · FY2025 · CA
Single-Cell, Spatial and Functional Dissection of Cancer Cell States, Co-Evolving Ecosystems, and Vulnerabilities During Tumor Progression and Metastasis
$384,868Benjamin Izar · Columbia University Health Sciences · U54 · FY2023 · CA
Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer
$384,867Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Role of Desmoglein 1 in Keratinocyte-Melanocyte Communication and Melanoma
$384,849Kathleen Janee Green · Northwestern University At Chicago · R01 · FY2023 · CA
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas
$384,846W Mark Saltzman · Yale University · R01 · FY2018 · CA
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas
$384,846W Mark Saltzman · Yale University · R01 · FY2020 · CA
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas
$384,846W Mark Saltzman · Yale University · R01 · FY2017 · CA
Impact of chronic intermittent hypoxia on the bone marrow
$384,838Melissa Lowe Bates · University Of Iowa · R56 · FY2020 · HL
Understanding the role of κB-Ras proteins in tumorigenesis
$384,782Sankar Ghosh · Columbia University Health Sciences · R01 · FY2020 · CA
Understanding the role of κB-Ras proteins in tumorigenesis
$384,782Sankar Ghosh · Columbia University Health Sciences · R01 · FY2016 · CA
Understanding the role of κB-Ras proteins in tumorigenesis
$384,782Sankar Ghosh · Columbia University Health Sciences · R01 · FY2017 · CA
Project 1 - Molecular Genetics of Human Papillomavirus Infection and Oncogenesis
$384,776Paul F Lambert · University Of Wisconsin-Madison · P01 · FY2020 · CA
Project 1 - Molecular Genetics of Human Papillomavirus Infection and Oncogenesis
$384,775Paul F Lambert · University Of Wisconsin-Madison · P01 · FY2018 · CA
Project 5 - EBV Drivers of Oncogenesis and Novel Therapies
$384,766Shannon Celeste Kenney · University Of Wisconsin-Madison · P01 · FY2019 · CA
Synergy of Radiation and Immunotherapy: New Approaches
$384,750Yang-Xin Fu · Ut Southwestern Medical Center · R01 · FY2018 · CA